Cerebral Ischemia Reperfusion Exacerbates and Pueraria Flavonoids Attenuate Depressive Responses to Stress in Mice

Tsinghua Science and Technology

Volumn 13, Issue 4, 2008, Pages 485-491

  Lan, Jiaqi ^a   Yan, Bin ^a   Zhao, Yu'nan ^a   Wang, Daoyi ^a   Hu, Jun ^a   Xing, Dongming ^a   Du, Lijun ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

antidepressant; cerebral ischemia reperfusion; post stroke depression; radix puerariae

Indexed keywords

AMINO ACIDS; BIOACTIVITY; GENE EXPRESSION; POWER SPECTRAL DENSITY; PULSE SHAPING CIRCUITS; SUGAR (SUCROSE); SURGERY;

BRAIN DAMAGE; CEREBRAL ISCHEMIA-REPERFUSION; FLAVONOIDS; MRNA EXPRESSION; PROTECTIVE EFFECT (PE); TSINGHUA UNIVERSITY; TYROSINE HYDROXYLASE (TH);

CHANNEL ESTIMATION;

EID: 47649092470     PISSN: 10070214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1007-0214(08)70078-6     Document Type: Article

References (39)

1. Wade D., Legh-Smith J., and Hewer R. Depressed mood after stroke: A community study of its frequency. Br. J. Psychiatry 151 (1987) 200-205
2. Morris P., Robinson R., and Raphael B. Prevalence and course of depressive disorders in hospitalized stroke patients. Int. J. Psychiatry Med. 20 (1990) 349-364
3. Parikh R., Robinson R., Lipsey J., et al. The impact of post-stroke depression on recovery in activities of daily living over two years follow-up. Arch. Neurol. 47 (1990) 785-789
4. Mayberg H., Robinson R., Wong D., et al. PET imaging of cortical S2-serotonin receptors after stroke: Lateralized changes and relationship to depression. Am. J. Psychiatry 145 (1988) 937-943
5. Bryer J., Starkstein S., Votypka V., et al. Reduction of CSF monoamine metabolites in post-stroke depression. J. Neurospcyhiatr. Clin. Neurosci. 55 (1992) 377-382
6. Andersen G., Vestergaard K., Riis J., et al. Incidence of post-stroke depression during the first year in a large unselected stroke population determined using a valid standardized rating scale. Acta. Psychiatr. Scand. 90 3 (1994) 190-195
7. Francisco G. An overview of post-stroke depression. N. J. Med. 90 9 (1993) 686-689
8. Gustafson Y., Nilsson I., Mattsson M., et al. Epidemiology and treatment of post stroke depression. Drugs Aging 7 4 (1995) 298-309
9. Lai X., and Tang B. Recent advances in the experimental study and clinical application of Pueraria lobata (Willd) Ohwi. China Journal of Chinese Materia Medica 14 5 (1989) 308-311 (in Chinese).
10. Wang L., Zhao A., Wang F., et al. Protective effect of puerarin on acute cerebral ischemia in rats. China Journal of Chinese Materia Medica 22 12 (1997) 752-754 (in Chinese).
11. Yan B., Wang D., and Xing D. The antidepressant effect of ethanol extract of Radix puerariae in mice exposed to cerebral ischemia reperfusion. Pharmacology, Biochemistry and Behavior 78 2 (2004) 319-325
12. Chuang D., Zsilla G., and Costa E. Turnover rate of tyrosine hydroxylase during trans-synaptic induction. Mol. Pharmacol. 11 (1975) 784-794
13. Ketnansky R., Weise V., and Kopin I. Elevation of adrenal tyrosine hydroxylase and phenylethanolamine-N-methyl transferase by repeated immobilization of rats. Endocrinogy 87 (1970) 744-749
14. Masserano J., and Weiner N. The rapid activation of tyrosine hydroxylase by the subcutaneous injection of formaldehyde. Life Science 29 (1981) 2025-2029
15. Jiang J., Sato S., and Yamanaka N. Changes in cerebral blood flow and blood brain barrier in the gerbil hippocampal CA1 region following repeated brief cerebral ischemia. Med. Electron. Microsc. 32 3 (1999) 175-183
16. Porsolt R., Bertin A., and Jalfre M. Behavioral despair in mice: A primary screening test for antidepressants. Arch. Int. Pharmacodyn Ther. 229 (1977) 327-336
17. Steru L., Chermat R., Thierry B., et al. The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology (Berl) 85 (1985) 367-370
18. Matthews K., Forbes N., and Reid I. Sucrose consumption as an hedonic measure following chronic unpredictable mild stress. Physiology & Behavior 57 2 (1995) 241-248
19. Wong H., Anderson W., Cheng T., et al. Monitoring mRNA expression by polymerase chain reaction: The 'primer-dropping' method. Anal. Biochem. 223 (1994) 251-258
20. Takeda H., Tsuji M., and Matsumiya T. Formation mechanisms of stress adaptation: Role of functional coupling of glucocorticoids and brain serotonergic nervous system. Japanese Journal of Neuropsychopharmacology 20 (2000) 83-91 (in Japanese).
21. Willner P., Towell A., and Sampson D. Reduction of sucrose prederence by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 93 (1987) 358-364
22. Muscait R., and Willner P. Suppression of sucrose drinking by chronic mild unpredictable stress: A methodological analysis. Neurosci. BioBehav. Rev. 16 4 (1992) 507-517
23. Willner P., Muscait R., and Papp M. Chronic mild stress-induced anhedonia: A realistic animal model of depression. Neurosci. BioBehav. Rev. 16 4 (1992) 525-534
24. Lewinsohn P., Yougren M., and Grosscup S. Reinforcement and depression. In: Depue R. (Ed). The Psychobiology of the Depressive Disorders: Implications for the Effects of Stress (1979), Academic Press, New York
25. Muscart R., Towell A., and Willner P. Changes in dopamine autoreceptor sensitivity in an animal model of depression. Psychopharmacology 94 (1988) 545-550
26. Muscat R., Sampson D., and Willner P. Dopamine mechanism of imipramine action in an animal model of depression. Biol. Psychiatry 28 (1990) 223-230
27. Muscait R., Papp M., and Willner P. Antidepressant-like effects of dopamine agonists in an animal model of depression. Biol. Psychiatry 31 9 (1992) 937-946
28. Bacopoulos N., and Bhatnagar R. Correlation between tyrosine hydroxylase activity and catecholamine concentration or turnover in brain regions. J. Neurochem. 29 (1977) 639-643
29. Masserano J., and Weiner N. Tyrosine hydroxylase regulation in the central nervous system. Mol. Cel. Biochem. 53-54 (1983) 129-152
30. Chuang D., Zsilla G., and Costa E. Turnover rate of tyrosine hydroxylase during trans-synaptic induction. Mol. Pharmacol. 11 (1975) 784-794
31. Ketnansky R., Weise V., and Kopin I. Elevation of adrenal tyrosine hydroxylase and phenylethanolamine-N-methyl transferase by repeated immobilization of rats. Endocrinogy 87 (1970) 744-749
32. Masserano J., and Weiner N. The rapid activation of tyrosine hydroxylase by the subcutaneous injection of formaldehyde. Life Science 29 (1981) 2025-2029
33. Yan B., Xing D., Sun H., et al. The dynamic change of monoamine neurotransmitters and their metabolite in various brain regions of cerebral ischemia reperfusion mice. Chinese Pharmacological Bulletin 19 11 (2003) 1264-1269 (in Chinese).
34. Montgomery S. Is there a role for a pure noradrenergic drug in the treatment of depression?. European Neuropsychopharmacology 7 Suppl. 1 (1997) S3-S9
35. Sacchetti G., Bernini M., Gobbi M., et al. Chronic treatment with desipramine facilitates its effect on extracellular norarenaline in rat hippocampus: Studies on the role of presynaptic alpha (2)-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol. 363 1 (2001) 66-72
36. Langer S. Presynaptic regulation of the release of catecholamines. Pharmacol Rev. 32 (1981) 337-362
37. Sulser F., Vetulani J., and Mobley P. Mode of action of antidepressant drugs. Biochem. Pharmacol 27 (1978) 257-261
38. Serra G., Agriolas A., Klimek V., et al. Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity. Life Science 25 (1979) 415-423
39. De Simoni M., Dal Toso G., Algeri S., et al. Differences in the effect of the antidepressant amineptine on striatal and limbic DOPAC measured by HPLC-ECD and in vivo voltametry. Eur. J. Pharmacol. 123 (1986) 433-439